GENEVA, May 17 -- NANJING PROBIO BIOTECH CO., LTD. (RM 4010, 28 Yongxi Road, Jiangning District (Jiangning High-tech Park)Nanjing, Jiangsu 211100), 南京蓬勃生物科技有限公司 (中国江苏省南京市江宁区雍熙路28号4010室(江宁高新园)) filed a patent application (PCT/CN2024/130101) for "FULLY HUMAN ANTIBODY TARGETING HUMAN PD-L1" on Nov 06, 2024. With publication no. WO/2025/098364, the details related to the patent application was published on May 15, 2025.
Notably, the patent application was submitted under the International Patent Classification (IPC) ...